Post by
KingAbeNYC on Sep 27, 2021 11:35am
More Bad News for Biogen's Aducanumab "Worst Decision"
The road to Aduhelm: What one ex-FDA adviser called 'probably the worst drug approval decision in recent US history' for an Alzheimer's treatment
https://www.cnn.com/2021/09/26/politics/alzheimers-drug-aduhelm-fda-approval/index.html
Comment by
DavidKingCanada on Sep 27, 2021 11:37am
Note; Biogen's Stock is back to the levels it was PRE-Approval - 280.00 USD
Comment by
retiredcop on Sep 27, 2021 12:32pm
Excellent news for us..everyone sees a problem.. And are anxously looking for an alternative....
Comment by
JackRedwood on Sep 27, 2021 1:22pm
I sure hope PMN receives more coverage!
Comment by
Speyeder999 on Sep 27, 2021 2:18pm
RC, what do you suppose the chances of hearing news on cell line development before year's end are?
Comment by
bball67 on Sep 27, 2021 2:48pm
I recall it was in corporate presentation of several months ago, with a 4th quarter 2021 target date.
Comment by
retiredcop on Sep 27, 2021 3:21pm
That sounds about right 6 to 7 months from the time the manufacturer got word to start
Comment by
Speyeder999 on Sep 27, 2021 3:58pm
Thanks for all the replies. 4 quarter begins this week! Encouraging!
Comment by
retiredcop on Sep 27, 2021 5:11pm
I strongly believe that we will see Advanced Life Support news before anything ...